We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Ne... Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. Show more
-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke Shepherd Center, a top neurorehabilitation hospital, is the...
-- Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) Over 28,000 cases of multiple sclerosis (MS) are reported to the VA annually...
-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...
NEWTOWN, Pa., March 15, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic...
-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month Study will evaluate the use of Portable Neuromodulation Stimulator (PoNS®) for gait and balance deficits in...
NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic...
-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.63 | -36.7945823928 | 4.43 | 4.6892 | 2.35 | 59569 | 3.09224177 | CS |
4 | -3.04 | -52.0547945205 | 5.84 | 6.79 | 2.35 | 37095 | 4.73559089 | CS |
12 | -3.49 | -55.4848966614 | 6.29 | 7.188 | 2.35 | 274317 | 5.98256965 | CS |
26 | -5.08 | -64.4670050761 | 7.88 | 9.5 | 2.35 | 211301 | 6.18582105 | CS |
52 | -5.7 | -67.0588235294 | 8.5 | 14.44 | 2.35 | 363037 | 8.24984781 | CS |
156 | -846.7 | -99.6703943496 | 849.5 | 863 | 2.35 | 690472 | 39.28252138 | CS |
260 | -4092.2 | -99.9316239316 | 4095 | 5792.5 | 2.35 | 558933 | 331.44494404 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions